Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: Randomized phase II study Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Genetic Variation
  • Guidelines as Topic
  • Sequence Analysis, DNA

abstract

  • NCT01506609.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdx505

PubMed ID

  • 29045554

Additional Document Info

start page

  • 154

end page

  • 161

volume

  • 29

number

  • 1